ABSTRACT
Objectives To evaluate the long-term angiographic patency of saphenous vein grafts (SVG) harvested using the no-touch technique compared to the conventional technique.
Methods This was a single-center, retrospective, cohort study. The inclusion criteria were individuals who underwent a CABG (coronary artery bypass grafting) between January 1995 and July 2020, and who successively needed a clinically-driven angiography. The primary endpoint was long-term patency. The secondary endpoints were differences in patency based on sub-group analysis (single vs. sequential graft, divided by target vessel).
Results The study included 1520 individuals (618 no-touch, 825 conventional and 77 arterial grafts). The mean clinical follow-up time was 8.4 years ± 5.5 years. The patency per patient was 70.7% in the no-touch grafts vs. 46.7% in the conventional grafts (p < 0.001, OR = 2.8). The graft patency was 75.9% in the no-touch grafts vs. 62.8% in the conventional grafts (p < 0.001, OR= 1.8).
Conclusions The no-touch vein grafts were associated with statistically significantly higher patency at long-term compared to the conventional grafts.
Clinical Trial Registration NCT04656366, 7 December 2020
Clinical Perspective
- What is new?
➣ The largest follow-up of the patency of no-touch vein grafts in the international literature.
➣ Patients with a no-touch vein graft had significantly better patency (p < 0.001) at mean follow-up of more than 8 years.
- What are the clinical implications?
➣ Consequent reduction in cardiovascular events after no-touch vein graft.
➣ Benefits at individual level due to fewer episodes of re-angina and myocardial infarction, and fewer coronary interventions.
➣ Benefits at community level due to fewer re-hospitalizations and a reduction in healthcare costs.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
Clinical Trial Registration: NCT04656366, 7 December 2020
Funding Statement
This work was supported by Region Örebro County through the regional research board (grant OLL- OLL-935188, 18 January 2020).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Regional Ethics Review Board in Uppsala (Regionala etikprövningsnämnden i Uppsala). Dnr 2020/03890.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Non-standard abbreviations and non-standard acronyms
- A
- arterial graft
- BMS
- bare metal stent
- C
- conventional
- CABG
- coronary artery bypass grafting
- DA
- diagonal artery
- DAPT
- double antiplatelet therapy
- DES
- drug-eluting stent
- EF
- ejection fraction
- FFR
- fractional flow reserve
- iFR
- instantaneous wave-free ratio
- IQR
- interquartile range
- LAD
- left anterior descending artery
- LITA
- left internal thoracic artery
- MA
- marginal artery
- MACE
- major adverse cardiac events
- MI
- myocardial infarction
- NT
- no-touch
- OR
- odds ratio
- PCI
- percutaneous coronary intervention
- RCA
- right coronary artery
- RITA
- right internal thoracic artery
- SD
- standard deviation
- SVG
- saphenous vein graft
- TIMI
- thrombolysis in myocardial infarction
- TVR
- target vessel revascularization